Fintel reports that on May 19, 2026, Wolfe Research initiated coverage of Tyra Biosciences (NasdaqGS:TYRA) with a Peer Perform recommendation.
Analyst Price Forecast Suggests 52.23% Upside
As of May 14, 2026, the average one-year price target for Tyra Biosciences is $51.41/share. The forecasts range from a low of $37.37 to a high of $61.95. The average price target represents an increase of 52.23% from its latest reported closing price of $33.77 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Tyra Biosciences is 21MM. The projected annual non-GAAP EPS is -1.06.
What is the Fund Sentiment?
There are 171 funds or institutions reporting positions in Tyra Biosciences. This is an decrease of 56 owner(s) or 24.67% in the last quarter. Average portfolio weight of all funds dedicated to TYRA is 1.13%, an increase of 63.57%. Total shares owned by institutions increased in the last three months by 31.03% to 66,657K shares. 
The put/call ratio of TYRA is 1.74, indicating a bearish outlook.
What are Other Shareholders Doing?
Ra Capital Management holds 12,199K shares representing 20.51% ownership of the company. No change in the last quarter.
Nextech Invest holds 4,056K shares representing 6.82% ownership of the company. No change in the last quarter.
Janus Henderson Group holds 3,891K shares representing 6.54% ownership of the company. In its prior filing, the firm reported owning 2,935K shares , representing an increase of 24.55%. The firm decreased its portfolio allocation in TYRA by 19.99% over the last quarter.
Alta Partners Management Company holds 3,823K shares representing 6.43% ownership of the company. No change in the last quarter.
Farallon Capital Management holds 3,581K shares representing 6.02% ownership of the company. In its prior filing, the firm reported owning 2,067K shares , representing an increase of 42.28%. The firm increased its portfolio allocation in TYRA by 204.91% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
